Tarun Chakravarty

Showing 1-11 of 11 articles

Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trial

Chakravarty T, Henry T, Kittleson M, Lima J, Siegel R, Slipczuk L, Pogoda J, Smith R, Malliaras K, Marbán L, Ascheim D, Marbán E, Makkar R

July 17, 2020 | 10.4244/EIJ-D-19-00035

Interventions for valvular disease

High-pressure post-dilation following transcatheter valve-in-valve implantation in small surgical valves

Chakravarty T, Cox J, Abramowitz Y, Israr S, Uberoi A, Yoon S, Dey D, Zadeh P, Cheng W, Makkar R

June 20, 2018 | 10.4244/EIJ-D-17-00563

Characteristics and outcome following transcatheter aortic valve replacement in patients with severe aortic stenosis with low flow

Abramowitz Y, Chakravarty T, Pibarot P, Maeno Y, Kawamori H, Anderson D, Mangat G, Nakamura M, Cheng W, Makkar R

December 8, 2017 | 10.4244/EIJ-D-17-00139

Interventions for valvular disease

Optimal sizing for SAPIEN 3 transcatheter aortic valve replacement in patients with or without left ventricular outflow tract calcification

Maeno Y, Abramowitz Y, Jilaihawi H, Israr S, Yoon S, Sharma R, Kazuno Y, Kawamori H, Miyasaka M, Rami T, Mangat G, Takahashi N, Okuyama K, Kashif M, Chakravarty T, Nakamura M, Cheng W, Makkar R

April 7, 2017 | 10.4244/EIJ-D-16-00806

Interventions for valvular disease

Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?

Chakravarty T, Abramowitz Y, Jilaihawi H, Makkar R

September 18, 2016 | 10.4244/EIJV12SYA7

Interventions for valvular disease

The clinical impact of vascular complications as defined by VARC-1 vs. VARC-2 in patients following transcatheter aortic valve implantation

Okuyama K, Jilaihawi H, Abramowitz Y, Kashif M, Patel J, Pokhrel H, Chakravarty T, Nakamura M, Cheng W, Makkar R

August 5, 2016 | 10.4244/EIJV12I5A104

Coronary interventions

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

Pyxaras S, Hunziker L, Chieffo A, Meliga E, Latib A, Park S, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar R, Palacios I, Kim Y, Buszman P, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Serruys P, Colombo A, Naber C

August 5, 2016 | 10.4244/EIJV12I5A102

Interventions for valvular disease

Feasibility and safety of balloon-expandable transcatheter aortic valve implantation with moderate or without predilatation

Abramowitz Y, Jilaihawi H, Chakravarty T, Kashif M, Matar G, Hariri B, Patel J, Sharma R, Cheng W, Makkar R

February 19, 2016 | 10.4244/EIJV11I10A229

Clinical impact of coronary protection during transcatheter aortic valve implantation: first reported series of patients

Abramowitz Y, Chakravarty T, Jilaihawi H, Kashif M, Kazuno Y, Takahashi N, Maeno Y, Nakamura M, Cheng W, Makkar R

September 22, 2015 | 10.4244/EIJV11I5A112

Heart-rate adjustment of transcatheter haemodynamics improves the prognostic evaluation of paravalvular regurgitation after transcatheter aortic valve implantation

Jilaihawi H, Chakravarty T, Shiota T, Rafique A, Harada K, Shibayama K, Doctor N, Kashif M, Nakamura M, Mirocha J, Rami T, Okuyama K, Cheng W, Sadruddin O, Siegel R, Makkar R

August 20, 2015 | 10.4244/EIJY14M12_08

Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry

Meliga E, De Benedictis M, Chieffo A, Latib A, Park S, Kim Y, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P, Bande M, Chakravarty T, Mehran R, Naber C, Scrocca I, Margey R, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Conte M, Serruys P, Colombo A

November 29, 2013 | 10.4244/EIJV9I7A133

Latest news

NEW ISSUE

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

August 7, 2020

New

Ahead of Print: Transcatheter mitral replacement after AVR

August 13, 2020

Editorial

"Minimalist” TAVI during the COVID-19 pandemic: previously optional but now a necessity

D. Wood

August 13, 2020

Guidance Papers

Guidelines, consensus & position papers

June 25, 2020

PCR Trials

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

Editorial

IVUS for guidance of coronary interventions: applying optimisation targets to improve clinical outcomes

K. Koskinas

August 13, 2020

JAA

This Week's JAA's: Real-world Use of the Evolut PRO Valve...